Menu

Industry Briefs

A report on genetically engineered plants predicts that they will begin reaching the marketplace within five years, but when they do, high research and testing costs will allow only the largest companies to compete in the field. Gerald Campbell, a St. Louis biochemist and one of the authors of the report, says the big companies likely to benefit from the technology are Calgene, Du Pont, and Monsanto. Under a contract with Campbell Soup, Calgene is now engaged in field trials of a genetically en

Oct 16, 1989
The Scientist Staff

A report on genetically engineered plants predicts that they will begin reaching the marketplace within five years, but when they do, high research and testing costs will allow only the largest companies to compete in the field. Gerald Campbell, a St. Louis biochemist and one of the authors of the report, says the big companies likely to benefit from the technology are Calgene, Du Pont, and Monsanto. Under a contract with Campbell Soup, Calgene is now engaged in field trials of a genetically engineered tomato. Through nonexpression of a gene, Calgene researchers have altered the enzyme that causes the softening of ripe tomatoes, thus allowing the plant to spend more time on the vine before harvest. Other promising avenues of research include plants that manufacture their own pesticides and herbicides. Campbell, who wrote the report for Frost & Sullivan Inc., a New York-based market research firm, could not say how much of an impact genetically engineered plants will have on agriculture in the near future.

Biotech Data Resource

Two charts that sort out the many sources of commercial biotechnology information have been compiled by the North Carolina Biotechnology Center. The charts describe 24 computer databases and their vendors and are available from the center at no charge. One chart lists the producers, vendors, updating frequencies, costs, years of coverage, and scope of coverage of the 24 databases that have been most useful to the center’s Biotechnology Information Division. A “hits per topic” column allows users to determine how appropriate a specific database might be for their business or research needs.

The second chart recommends 13 vendors of business information data services. These are companies that access a number of databases for individual users with limited on-line experience. For example, 16 of the databases listed in the first chart can be reached through Western Union’s InfoMaster database and 21 through Dialog’s Business Connection.

Requests for free copies of the database charts should be directed to Dina Murray, information assistant, at the North Carolina Biotechnology Center, RO. Box 13547, Research Triangle Park, NC. 27709-3547; (919)541-9366.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.